The Gene and Cell Therapies Targeting CNS Disorders Market encompasses therapies that targets the central nervous system (CNS) disorders such as Alzheimer's disease, Parkinson's disease, spinal cord injury, stroke, and others. The therapies involve cellular and genetic-based approaches to treat these conditions by replacing or repairing damaged or dysfunctional cells or genes in the brain or spinal cord. The therapies have advantages such as targeted treatment, reduced systemic toxicity, and ... Read more
